Amarell, Katherine
Jaysing, Anna
Mendez, Christopher
Haas, Jonathan A.
Blacksburg, Seth R.
Katz, Aaron E.
Sanchez, Astrid
Tong, Angela
Carpenter, Todd
Witten, Matthew
Collins, Sean P.
Lischalk, Jonathan W.
Funding for this research was provided by:
Accuray Research Grant (20-00-00-1003866)
Article History
Received: 20 August 2021
Accepted: 9 March 2022
First Online: 2 April 2022
Declarations
:
: This single institutional review of patients treated with SBRT for prostate cancer was approved by the local Institutional Review Board (Study # 00001269).
: Not applicable.
: Jonathan A. Haas, Seth R. Blacksburg, Sean P. Collins, and Jonathan W. Lischalk are paid speakers for Accuray. The remaining authors have no competing interests.